Can ultrasound replace CT scans for aneurysm patients?

NCT ID NCT01230203

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 659 patients who had surgery to fix an abdominal aortic aneurysm. Researchers compared two types of scans—CT and ultrasound—to see which one is better at finding problems like leaks or blockages after the repair. The goal was to find out if ultrasound could be used instead of CT to reduce radiation and cost.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

659 people

The number who actually took part.

Started

Dec 2010

Finished

Jun 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who were followed after EVAR, whatever the trademark and the model of the stentgraft (bi-iliac or mono-iliac) * Age \> 18 years old * Patient with social insurance * Signature of informed consent Exclusion Criteria: * patients who underwent EVAR with a fenestrated or branched stentgraft * Obese patients (BMI \> 30) * Patients with severe renal insufficiency (Creatinine Clearance \< 30 ml/mn) * Patients who can't practice both an CT scan with iode injection and duplex ultrasound test over a period of one month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal aortic aneurysm are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HM Service de Chirurgie vasculaire

    Marseille, France

  • AP-HP - Pitié Salpétrière - Service de Chirurgie Vasculaire

    Paris, France

  • AP-HP Créteil - Service de chirurgie vasculaire

    Créteil, France

  • APHM - Hôpital Nord - Service de Chirurgie Vasculaire

    Marseille, France

  • CHRU Lille Service de Chirurgie Vasculaire

    Lille, France

  • CHU Clermont-ferrand - Service de Chirurgie Vasculaire

    Clermont-Ferrand, France

  • CHU d'Amiens - Service de Chirurgie Vasculaire

    Amiens, France

  • CHU d'Angers - Service de Chirurgie Vasculaire

    Angers, France

  • CHU de Besançon - Service de Chirurgie Vasculaire

    Besançon, France

  • CHU de Bordeaux - Service de Chirurgie Vasculaire

    Bordeaux, France

  • CHU de Caen - Service de Chirurgie Vasculaire

    Caen, France

  • CHU de Dijon - Service de Chirurgie Vasculaire

    Dijon, France

  • CHU de Grenoble - Service de Chirurgie Vasculaire

    Grenoble, France

  • CHU de Montpellier - Service de Chirurgie Vasculaire

    Montpellier, France

  • CHU de Nantes - Service de Chirurgie Vasculaire

    Nantes, France

  • CHU de Nice - Service de chirurgie vasculaire

    Nice, France

  • CHU de Rouen - Service de Chirurgie Vasculaire

    Rouen, France

  • CHU de St Etienne - Service de Chirurgie Vasculaire

    Saint-Etienne, France

  • CHU de Strasbourg - Service de Chirurgie Vasculaire

    Strasbourg, France

  • CHU de Toulouse - Service de Chirurgie Vasculaire

    Toulouse, France

  • HCL - Service de Chirurgie Vasculaire

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.